Diabetes Insights - Breakthroughs and Innovators cover art

Diabetes Insights - Breakthroughs and Innovators

Diabetes Insights - Breakthroughs and Innovators

Written by: EASD - European Association for the Study of Diabetes
Listen for free

About this listen

 EASD presents: Diabetes Insights - Breakthroughs and Innovators Join us for expert interviews and discussions on the latest advances in diabetes research. Discover how groundbreaking medicines and cutting-edge technologies are shaping the future of diabetes treatment and management. Get inspired by the stories of distinguished researchers whose discoveries and contributions have transformed our understanding of diabetes. These podcasts were recorded at the EASD Annual Meeting 2024 in Madrid, Spain. You can learn more about the research discussed by watching the scientific presentations in the EASD Media Centre (https://www.easd.org/media-centre/home.html). New episode released every Friday. Science
Episodes
  • Diet and Exercise: When, How and What Matters?

    Diet and Exercise: When, How and What Matters?
    Jan 23 2026
    In this episode, Prof. Frédéric Gachon and Prof. Olga Pivovarova-Ramich explore how the timing of eating and exercise influences metabolism and diabetes risk. Drawing on recent research in chronobiology, they discuss circadian rhythms, chronotype, late-night eating, intermittent fasting, and how aligning daily behaviours with our internal clocks may improve metabolic health and insulin sensitivity. Prof. Gachon and and Prof. Pivovarova-Ramich explore how eating late or at the wrong time disrupts your body’s rhythm, and how different chronotypes (early risers vs night owls) respond to meal timing. They also touch on the growing popularity of intermittent fasting and time-restricted eating, as well as exercise timing and its connection to performance and sleep. Listen in now to understand how the timing of diet and exercise can improve health outcomes, especially for individuals living with diabetes.
    Show More Show Less
    13 mins
  • SURPASS-CVOT: A comparison of Tirzepatide and Dulaglutide

    SURPASS-CVOT: A comparison of Tirzepatide and Dulaglutide
    Jan 16 2026
    In this weeks episode of Diabetes Insights - Breakthroughs and Innovators, experts discuss the highly anticipated SURPASS CVOT trial, a head-to-head cardiovascular outcomes study comparing tirzepatide 15 mg weekly with dulaglutide 1.5 mg weekly in people with type 2 diabetes. With over 13,000 participants, the trial demonstrates that tirzepatide provides equivalent cardioprotective benefits to dulaglutide, confirming its role in improving both glycaemic control and cardiovascular outcomes. EASD TV Host Vivienne Parry sits with Prof. Tina Vilsbøll (EASD Honorary Secretary) and Prof. Hertzel Gerstein (EASD Independent Advisor and McMaster University) to unpack the trial’s implications for clinical practice, highlighting how outcomes trials like this inform personalised medicine, integrate care between diabetologists and cardiologists, and generate new hypotheses in areas such as liver disease, cognitive function, and obesity management. This episode underscores the growing importance of transdisciplinary approaches in diabetes care, where therapies can target multiple complications simultaneously. Join us to understand how outcomes trials like SURPASS-CVOT are shaping guidelines, expanding treatment options, and improving care for people living with type 2 diabetes worldwide.
    Show More Show Less
    10 mins
  • What are the Hot Topics in Diabetes Research from a Journal's Perspective - Diabetologia

    What are the Hot Topics in Diabetes Research from a Journal's Perspective - Diabetologia
    Jan 9 2026
    In our first episode of 2026, Prof. Hindrik Mulder, Editor-in-Chief of Diabetologia, offers a journal’s-eye view of the most exciting and challenging developments in diabetes research today. Drawing on his unique overview of submissions from across the global research community, prof. Mulder discusses emerging breakthroughs such as hypoimmune stem cell-based therapies that are transforming from theoretical possibilities into scalable, off-the-shelf treatments for diabetes. Prof. Mulder discusses how these innovations could revolutionise diabetes care by overcoming the historical barriers of islet transplantation. We further explore Diabetologia's special 2025 issue on "Opportunities and Challenges in Diabetes," which tackles the critical issues of healthcare disparity, access, and equity. Prof. Mulder passionately addresses why diversity in research is essential to understanding disease heterogeneity and why the scientific community must continue advocating for inclusive research despite political headwinds. Learn about the journal's innovative approach to incorporating patient perspectives in research design, the appointment of a dedicated DEI editor, and the exciting launch of Metabologia - Diabetologia's new sister journal - covering the expanding landscape of metabolic disorders. This conversation reminds us that embracing complexity and acknowledging what we don't know is fundamental to advancing diabetes science.
    Show More Show Less
    15 mins
No reviews yet